Nutanix: Bookings Strength Obscured by Supply Chain and a Wait-and-See Valuation
Core Conclusion
Nutanix’s Q3 revenue beat and accelerating bookings growth confirm the long-term platform thesis, but Q4 guidance missed consensus again, proving that supply chain constraints and macro overhangs continue to delay the translation of demand into reported revenue. A 20%+ TCV bookings growth rate and a 25% cRPO bookings acceleration represent genuine demand strength, yet these are not cleanly converting into revenue or ARR metrics. The stock’s re-rating requires visible, linear revenue conversion—a condition absent today. We maintain Equal-weight with a revised price target of $55.
Where the Revenue Signal Breaks Down
The core distortion is a supply-driven gap between bookings and recognized revenue. Management disclosed 20%+ YoY TCV bookings growth and raised full-year expectations, while cRPO bookings accelerated to ~25% YoY from ~11% and ~7% in the prior two quarters. Despite this, Q4 revenue guidance of $725–745M missed the Street midpoint, and NNARR decelerated again with NRR at 106%.
The investment implication is straightforward: a healthy demand signal is being partially nullified by persistent server hardware shortages, elevated pricing, and extended lead times ranging from a few weeks to six months. Until lead times normalize, reported revenue growth will understate underlying business momentum, keeping the stock’s valuation multiple compressed. Demand exists; revenue delivery is deferred, not destroyed, but the Street will not pay for it until it shows up in the income statement.
Evidence of Platform Expansion, Not Just HCI Resilience
Nutanix’s strategy to expand beyond core HCI is showing early commercial proof. Callback commentary confirmed customer wins across external storage, NC2, AI/Kubernetes, and database automation—consistent with the framework laid out at Investor Day. The 730 new logos added (+18% YoY) and commentary suggesting that hardware constraints are altering deployment paths (e.g., more NC2/public cloud usage) rather than impairing demand support the idea that the platform value proposition is growing.
The investment implication: leading indicators of platform adoption are positive but too early-stage to alter the near-term revenue equation. These wins provide optionality for a re-rating catalyst if supply conditions ease, but they do not yet constitute a standalone reason to own the stock ahead of cleaner FY27 revenue visibility.
Key Risks
- Revenue visibility risk: Persistent supply chain constraints could lead to further guidance misses, eroding investor confidence in management’s full-year revenue trajectory.
- ARR quality risk: The deceleration in NNARR alongside 106% NRR suggests that supply chain headwinds are stretching replacement cycles and dampening upsell activity, potentially compressing long-term growth rates if not resolved.
- Geographic concentration risk: The explicit callout of weaker new business performance in the Middle East (~5% exposure) indicates that macro headwinds are uneven, and any broadening of regional weakness would further pressure top-line growth.
Valuation and Trade Implication
We raise the price target to $55 from $53 on slightly higher confidence in the bookings trajectory, but the Equal-weight rating remains anchored to the absence of a near-term catalyst. The business has achieved attractive scale—$2.5B+ revenue, 20%+ non-GAAP operating margins, and ~30% FCF margins—and the Q3 margin beat to 22.3% demonstrates strong operating discipline. However, a long-term platform opportunity alone is insufficient for upside. The stock re-rates only when the supply chain fog lifts and FY27 revenue/ARR visibility improves. Until that inflection point is evident, risk-reward is balanced.